Matillon brings over twenty years of experience in senior financial management positions in leading technology organizations, including SITA, Hewlett-Packard and Electronic Arts.
St. Sulpice, SWITZERLAND, 11th January 2018 – Sophia Genetics, global leader in Data-Driven Medicine, announced today that Valentin Matillon has joined the company’s management team as Chief Financial Officer. He brings over twenty years of experience in senior financial management positions in leading technology organizations, including SITA, Hewlett-Packard and Electronic Arts.
“I am happy to welcome Valentin to our management team,” said Jurgi Camblong, CEO & Co-Founder of SOPHiA GENETICS. “His track record in transforming finance functions and supporting new acquisitions, along with his pragmatic and results-driven approach, make him a natural fit for the fast-paced culture of SOPHiA GENETICS. His role is key to the company as we continue to democratize Data-Driven Medicine worldwide.”
This management change comes at an important time as the company ramps up its efforts to conquer new markets and deploy innovative Data-Driven Medicine solutions. SOPHiA AI, the clinicians’ technology of choice for genomic analysis, has been deployed to over 400 healthcare institutions across 55 countries. It is paving the way towards a Collective Intelligence, and currently helps to diagnose a patient every 5 minutes. SOPHiA GENETICS’ innovative approach was recognized by the MIT Technology Review who ranked it amongst the 50 Smartest Companies in 2017.
“I am proud to take over the role of CFO of SOPHiA GENETICS. Our groundbreaking technology and approach are revolutionizing the healthcare field, improving the prognosis of patients worldwide, and I look forward to supporting the company through its journey of growth and development. This is a unique opportunity to play a part in history being made.” – Valentin Matillon
Valentin joins SOPHiA GENETICS from the Hobart Group where he served as Senior Director of Finance. Valentin was previously Senior Director, Corporate Finance and Performance Management, at SITA. Prior to that, he held Finance roles at Electronic Arts and Hewlett-Packard Europe. Valentin holds a BBA degree from the Institute des Hautes Etudes Economiques et Commerciales de Paris, and an MSc in Technology and Management from the Ecole centrale de Paris.
Valentin will be responsible for the company’s Finance and Accounting functions, previously managed by Marylin Mermod Schule who held the dual roles of CFO and Chief Operations Officer. Going forward, Marylin will fully dedicate her expertise to leading the company’s operations initiatives, and sustaining the international expansion of the group.
“I would like to thank Marylin for the outstanding contributions she has made as CFO of the company”, said Jurgi Camblong. “Since 2015, Marylin has led financial operations, built the accounting function, and successfully managed two fundraising series. I look forward to the impact she will make as she focuses solely on driving our operational management and development.”
About SOPHiA GENETICS
SOPHiA GENETICS: global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. The global network of 400 institutions from 55 countries that use the SOPHiA DDM® analytical platform powered by SOPHiA form the world’s largest clinical genomics community. By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to save lives equally. More info: http://www.sophiagenetics.com
SOPHiA GENETICS is on Twitter, follow @SOPHiAGENETICS | For media and journalist inquiries, please contact the SOPHiA GENETICS media relations team by either email or telephone: rchandramouli@sophiagenetics.com or +41 79 378 1543.
